Investigational drug · Phase 3
C.difficile vaccine
Also called: previously studied
Not approved by FDA. In 2 industry-sponsored Phase 2 or 3 trials that are active or finished in the last two years, most often for Clostridoides Difficile Associated Disease.
Phase 3Last checked: Nov 19, 2026Latest source record: Nov 18, 2026 (newest trial update)Source: ClinicalTrials.govMethods & limitations
Highest phase
Phase 3
Industry-sponsored trials
Phase 2 and 3 trials
2
2 still active
All registered trials
1
Any phase or sponsor naming "C.difficile vaccine"
First trial start
2023
Mar 23, 2023
Sponsors
Lead sponsors of its Phase 2 and 3 trials.
All registered trials by phase
Every ClinicalTrials.gov drug study naming "C.difficile vaccine", any sponsor or status.
Conditions studied
As listed on its trial records.
- Clostridoides Difficile Associated Disease
Largest trials
Live from ClinicalTrials.gov: studies naming "C.difficile vaccine" as an intervention, largest first.
- A Study to Learn About a Clostridioides Difficile Vaccine in People 65 Years of Age and OlderPivotal-lookingRecruiting
PfizerPfizer (PFE)
NCT07282665 · 32,500 participants (planned) · Start Dec 10, 2025 · Primary completion Dec 11, 2028
Drug: C.difficile vaccine · For: Clostridoides Difficile Associated Disease
Sites: Athens, Alabama; Guntersville, Alabama; Huntsville, Alabama · 185 sites in all
Newest research
PubMed records naming it or its code names, newest first.
- Dissociation and tautomerism of some amino-, nitro-, and aminonitrofluoresceins in DMSO: Either resolution or inversion of the Ka1 and Ka2 values.
Mchedlov-Petrossyan NO, Cheipesh TA, Shekhovtsov SV · Spectrochim Acta A Mol Biomol Spectrosc 2026
- Ragnarok: A flexible and RApid GeNe annotation (ROcKs) pipeline deployed through Nextflow.
Kuster RD, Smith ZC, Whitt L, et al. · Plant Genome 2026
- CTCF delimits a DNA methylation transition at the intergenic region between the embryonic and adult α-globin genes.
Tapia-Urzúa G, Núñez-Martínez HN, Garza-Manero S, et al. · Epigenetics 2026
- Culture-free supernatant of potential probiotic Bacillus albus attenuates the expression of biofilm-associated virulence determinants in Burkholderia thailandensis and Staphylococcus aureus.
Vinothkanna A, Dar OI, Chen L, et al. · Food Res Int 2026
- Zopapogene Imadenovec-drba Treatment for Adults With Recurrent Respiratory Papillomatosis: A Review.
Norberg SM, Misono S, Allen CT · JAMA Otolaryngol Head Neck Surg 2026
- How Is Music Selected for Psychedelic-Assisted Therapy? An Exploratory Survey Study of Practitioners and Patients.
Moskovitz M · ACS Pharmacol Transl Sci 2026
Names are merged from how sponsors list this drug on ClinicalTrials.gov, so an alias can occasionally belong to a related compound. Development status changes faster than registry records do. More from Pfizer.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.